The Impact of Policy Changes on Heroin and Nonmedical Prescription Opioid Use Among an Incarcerated Population in Kentucky,2008 to 2016

Abstract

In response to the opioid epidemic, there have been several national- and state-level policies enacted. Consideration of how criminal justice–involved individuals are affected by such policies has received limited attention, despite disproportionately higher use among this population. Bivariate statistics examined yearly trends, and logistic regressions examined demographic correlates of nonmedical prescription opioid and heroin use among Kentucky inmates over an 8-year time span of important national and local policy changes (N = 34,542). Results indicate that among incarcerated individuals, prior use of heroin increased 204% from 2008 to 2016, with increases possibly linked to key policy changes associated with OxyContin reformulation and state implementation of a prescription drug monitoring program. The current incarcerated population had more severe use patterns when considering general population research. Consideration of criminal justice–involved populations is crucial to understanding and treating the opioid epidemic.

Keywords

opioids trend criminal justice heroin nonmedical prescription opioid

Get full access to this article

View all access options for this article.

References

Aday

R. H.

Dye

M. H.

Kaiser

A. K.

(2014). Examining the traumatic effects of sexual victimization on the health of incarcerated women. Women & Criminal Justice, 24, 341-361. doi:10.1080/08974454.2014.909758

Ahmad

F. B.

Rossen

L. M.

Spencer

M. R.

Warner

Sutton

(2017). Provisional drug overdose death counts. Retrieved from https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

Alpert

Powell

Pacula

R. L.

(2018). Side-supply drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids. American Economic Journal: Economic Policy, 10(4), 1-35. doi:10.1257/pol.20170082

Altarum. (2018, February 2). Economic toll of opioid crisis in U.S. exceeded $1 trillion since 2001. Retrieved from https://altarum.org/news/economic-toll-opioid-crisis-us-exceeded-1-trillion-2001

Back

S. E.

Lawson

K. M.

Singleton

L. M.

Brady

K. T.

(2011). Characteristics and correlates of men and women with prescription opioid dependence. Addictive Behaviors, 36, 829-834. doi:10.1016/j.addbeh.2011.03.013

Back

S. E.

Payne

R. L.

Simpson

A. N.

Brady

K. T.

(2010). Gender and prescription opioids: Findings from the National Survey on Drug Use and Health. Addictive Behaviors, 35, 1001-1007. doi:10.1016/j.addbeh.2010.06.018

Belenko

Hiller

Hamilton

(2013). Treating substance use disorders in the criminal justice system. Current Psychiatry Reports, 15, Article 414. doi:10.1007/s11920-013-0414-z

Beletsky

(2018). Deploying prescription drug monitoring to address the overdose crisis: Ideology meets reality. Indiana Health Law Review, 15, 139-187.

Binswanger

I. A.

Stern

M. F.

Deyo

R. A.

Heagerty

P. J.

Cheadle

Elmore

J. G.

Koepsell

T. D.

(2007). Release from prison—A high risk of death for former inmates. New England Journal of Medicine, 356, 157-165. doi:10.1056/NEJMsa064115

10.

Birnbaum

H. G.

White

A. G.

Schiller

Waldman

Cleveland

J. M.

Roland

C. L.

(2011). Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Medicine, 12, 657-667. doi:10.1111/j.1526-4637.2011.01075.x

11.

Buchmueller

T. C.

Carey

(2017). The effect of prescription drug monitoring programs on opioid utilization in Medicare. Cambridge, MA: National Bureau of Economic Research.

12.

Cai

Crane

Poneleit

Paulozzi

(2010). Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004–2008. Journal of Pain & Palliative Care Pharmacotherapy, 24, 293-297. doi:10.3109/15360288.2010.503730

13.

Centers for Disease Control and Prevention. (2017, December 19). Drug overdose death data. Retrieved from https://www.cdc.gov/drugoverdose/data/statedeaths.html

14.

Centers for Disease Control and Prevention. (2018a, January 10). Drug overdose mortality by state. Retrieved from https://www.cdc.gov/nchs/pressroom/sosmap/drug_poisoning_mortality/drug_poisoning.htm

15.

Centers for Disease Control and Prevention. (2018b, August 2). Nonfatal drug overdoses. Retrieved from https://www.cdc.gov/drugoverdose/data/nonfatal.html

16.

Ciccarone

(2017). Fentanyl in the US heroin supply: A rapidly changing risk environment. The International Journal on Drug Policy, 46, 107-111. doi:10.1016/j.drugpo.2017.06.010

17.

Cicero

T. J.

Ellis

M. S.

Surratt

H. L.

Kurtz

S. P.

(2013). Factors influencing the selection of hydrocodone and oxycodone as primary opioids in substance abusers seeking treatment in the United States. Pain, 154, 2639-2648. doi:10.1016/j.pain.2013.07.025

18.

Compton

W. M.

Jones

C. M.

Baldwin

G. T.

(2016). Relationship between nonmedical prescription-opioid use and heroin use. New England Journal of Medicine, 374, 154-163. doi:10.1056/NEJMra1508490

19.

Cunningham

E. B.

Hajarizadeh

Amin

Bretana

Dore

G. J.

Degenhardt

. . . HITS-p Investigators. (2018). Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study. International Journal of Drug Policy, 54, 18-25. doi:10.1016/j.drugpo.2017.12.013

20.

Darke

(1998). Self-report among injecting drug users: A review. Drug and Alcohol Dependence, 51, 253-263. doi:10.1016/S0376-8716(98)00028-3

21.

Dumont

D. M.

Brockmann

Dickman

Alexander

Rich

J. D.

(2012). Public health and the epidemic of incarceration. Annual Review of Public Health, 33, 325-339. doi:10.1146/annurev-publhealth-031811-124614

22.

Haegerich

T. M.

Paulozzi

L. J.

Manns

B. J.

Jones

C. M.

(2014). What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug and Alcohol Dependence, 145, 34-47. doi:10.1016/j.drugalcdep.2014.10.001

23.

Hansen

Netherland

(2016). Is the prescription opioid epidemic a White problem? American Journal of Public Health, 106, 2127-2129. doi:10.2105/AJPH.2016.303483

24.

Ingram

D. D.

Franco

S. J.

(2014). 2013 NCHS urban-rural classification scheme for counties. Vital Health Statistics, 2(166), 1-73.

25.

Jones

C. M.

(2013). Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers—United States, 2002–2004 and 2008–2010. Drug and Alcohol Dependence, 132, 95-100. doi:10.1016/j.drugalcdep.2013.01.007

26.

Jones

C. M.

Logan

Gladden

R. M.

Bohm

M. K.

(2015). Vital signs: Demographic and substance use trends among heroin users—United States, 2002–2013. MMWR. Morbidity and Mortality Weekly Report, 64, 719-725.

27.

Kennedy-Hendricks

Gielen

McDonald

McGinty

E. E.

Shields

Barry

C. L.

(2016). Medication sharing, storage, and disposal practices for opioid medications among US adults. JAMA Internal Medicine, 176, 1027-1029. doi:10.1001/jamainternmed.2016.2543

28.

Keyes

K. M.

Cerdá

Brady

J. E.

Havens

J. R.

Galea

(2014). Understanding the rural–urban differences in nonmedical prescription opioid use and abuse in the United States. American Journal of Public Health, 104, e52-e59. doi:10.2105/AJPH.2013.301709

29.

Knighton

J.-S.

Stevens-Watkins

Staton

Pangburn

(2018). Trends and mental health correlates of nonmedical opioid use among criminal justice-involved African American men. Addictive Behaviors, 85, 14-20. doi:10.1016/j.addbeh.2018.04.022

30.

Martins

S. S.

Sarvet

Santaella-Tenorio

Saha

Grant

B. F.

Hasin

D. S.

(2017). Changes in US lifetime heroin use and heroin use disorder: Prevalence from the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry, 74, 445-455. doi:10.1001/jamapsychiatry.2017.0113

31.

Muhuri

P. K.

Gfroerer

Davies

M. C.

(2013). Associations of nonmedical pain reliever use and initiation of heroin use in the United States (CBHSQ Data Review). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/sites/default/files/DR006/DR006/nonmedical-pain-reliever-use-2013.htm

32.

Paulozzi

L. J.

(2012). Prescription drug overdoses: A review. Journal of Safety Research, 43, 283-289. doi:10.1016/j.jsr.2012.08.009

33.

Prescription Drug Monitoring Program Center of Excellence. (2016, May). PDMP prescriber use mandates: Characteristics, current status, and outcomes in selected states. Retrieved from http://www.pdmpassist.org/pdf/Resources/Briefing_on_mandates_3rd_revision_A.pdf

34.

Salisbury

E. J.

Van Voorhis

(2009). Gendered pathways: A quantitative investigation of women probationers’ paths to incarceration. Criminal Justice and Behavior, 36, 541-566. doi:10.1177/0093854809334076

35.

Slavova

Costich

J. F.

Bunn

T. L.

Luu

Singleton

Hargrove

S. L.

Ingram

(2017). Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance. International Journal of Drug Policy, 46, 120-129. doi:10.1016/j.drugpo.2017.05.051

36.

Substance Abuse and Mental Health Services Administration. (2017). Behavioral health barometer: Kentucky, volume 4: Indicators as measured through the 2015 National Survey on Drug Use and Health, the National Survey of Substance Abuse Treatment Services, and the Uniform Reporting System. (HHS Publication No. SMA–17–Baro–16–States–KY). Rockville, MD: Author.

37.

Van Handel

M. M.

Rose

C. E.

Hallisey

E. J.

Kolling

J. L.

Zibbell

J. E.

Lewis

Brooks

J. T

. (2016). County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. Journal of Acquired Immune Deficiency Syndromes, 73, 323-331. doi:10.1097/QAI.0000000000001098

38.

Victor

G. A.

Walker

Cole

Logan

T. K.

(2017). Opioid analgesics and heroin: Examining drug misuse trends among a sample of drug treatment clients in Kentucky. International Journal of Drug Policy, 46, 1-6. doi:10.1016/j.drugpo.2017.01.008

39.

Winkelman

T. N. A.

Chang

V. W.

Binswanger

I. A.

(2018). Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Network Open, 1(3), e180558. doi:10.1001/jamanetworkopen.2018.0558